Abstract
Omission of axillary lymph node dissection in patients with HER2-positive or triple-negative breast cancer who had 1-2 sentinel lymph node metastasis after neoadjuvant systemic therapy
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
